Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report

European Neuropsychopharmacology

Volumn 25, Issue 11, 2015, Pages 1981-1990

  Dinteren, Rik van ^a,b   Arns, Martijn ^b,c   Kenemans, Leon ^c   Jongsma, Marijtje L A ^d   Kessels, Roy P C ^a   Fitzgerald, Paul ^e   Fallahpour, Kamran ^f,g   Debattista, Charles ^g   Gordon, Evian ^g   Williams, Leanne M ^g  

^a RADBOUD UNIVERSITY   (Netherlands)

^b RESEARCH INSTITUTE BRAINCLINICS   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^e Australia   (Australia)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g NONE

Author keywords

Antidepressants; Event Related Potential (ERP); Major Depressive Disorder (MDD); Treatment prediction

Indexed keywords

ANTIDEPRESSANT AGENT; ESCITALOPRAM; SERTRALINE; VENLAFAXINE; CITALOPRAM;

ADULT; AGED; ANALYTIC METHOD; ANXIETY; ARTICLE; CLINICAL STUDY; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; EXACT LOW RESOLUTION TOMOGRAPHY; FEMALE; FUNCTIONAL NEUROIMAGING; HAMILTON DEPRESSION RATING SCALE; HUMAN; IMAGING SOFTWARE; LATENT PERIOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY (TOPIC); PARAHIPPOCAMPAL GYRUS; PHASE 4 CLINICAL TRIAL (TOPIC); POST HOC ANALYSIS; POSTERIOR CINGULATE; POWER ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; BRAIN; BRAIN MAPPING; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHASE 4 CLINICAL TRIAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SEXUAL DEVELOPMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN MAPPING; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SERTRALINE; SEX CHARACTERISTICS; TREATMENT OUTCOME; VENLAFAXINE HYDROCHLORIDE; YOUNG ADULT;

EID: 84947496208     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.07.022     Document Type: Article

References (50)

1. Arns M., Bruder G., Hegerl U., Spooner C., Palmer D.M., Etkin A., Fallahpour K., Gatt J.M., Hirshberg L., Gordon E. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study. Clin. Neurophysiol 2015, 10.1016/j.clinph.2015.05.032.
2. Arns M., Drinkenburg W.H.I.M., Fitzgerald P.B., Kenemans J.L. Neurophysiological predictors of non-response to rTMS in depression. Brain Stimul. 2012, 5:569-576.
3. Arns M., Etkin A., Hegerl U., Williams L.W., DeBattista C., Palmer D.M., Fitzgerald P.B., Harris A., deBeuss R., Gordon E. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?. Eur. Neuropsychopharmacol 2015.
4. Arns M., Gunkelman J., Breteler M., Spronk D. EEG phenotypes predict treatment outcome to stimulants in children with ADHD. J. Integr. Neurosci. 2008, 7:421-438.
5. Arns M., Olbrich S. Personalized medicine in ADHD and depression: use of pharmaco-EEG. Curr. Top Behav. Neurosci. 2014, 345-370. Springer-Verlag, Berlin.
6. Avery J.A., Drevets W.C., Moseman S.E., Bodurka J., Barcalow J.C., Simmons W.K. Major depressive disorder is associated with abnormal interoceptive activity and functional connectivity in the insula. Biol. Psychiatry 2014, 76:258-266.
7. Bruder G.E., Kayser J., Tenke C.E. Event-related Brain Potentials in Depression: Clinical, Cognitive and Neurophysiologic Implications. Event-related Potential Components: The Ups and Downs of Brainwave Recordings 2009, Oxford University Press, New York.
8. Bruder G.E., Tenke C.E., Stewart J.W., Towey J.P., Leite P., Voglmaier M., Quitkin F.M. Brain event-related potentials to complex tones in depressed patients: relations to perceptual asymmetry and clinical features. Psychophysiology 1995, 32:373-381.
9. Bruder G.E., Tenke C.E., Towey J.P., Leite P., Fong R., Stewart J.E., McGrath P.J., Quitkin F.M. Brain ERPs of depressed patients to complex tones in an oddball task: relation of reduced P3 asymmetry to physical anhedonia. Psychophysiology 1998, 35:54-63.
10. Coffman J.A., Torello M.W., Lewis C.E., Fortin L.D., Martin D.J. Event-related brain potentials in depressed patients treated with electroconvulsive therapy. Prog. Neuropsychopharmacol. Biol. Psychiatry 1989, 13:687-692.
11. Davidson R.J., Irwin W., Anderle M.J., Kalin N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am. J. Psychiatry 2003, 160:64-75.
12. Etkin A., Patenaude B., Song Y.J., Usherwood T., Rekshan W., Schatzberg A.F., Rush A.J., Williams L.M. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. Neuropsychopharmacology 2014.
13. Fava M., Rush A., Trivedi M.H., Nierenberg A.A., Thase M.E., Sackeim H.A., Quitkin F.M., Wisniewski S., Lavori P.W., Rosenbaum J.F., Kupfer D.J. Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr. Clin. N. Am. 2003, 26:457-494.
14. Friedman D. Cognition and aging: a highly selective overview of event-related potential (ERP) data. J. Clin. Exp. Neuropsychol. 2003, 25:702-720.
15. Gallinat J., Bottlender R., Juckel G., Munke-Puchner A., Stotz G., Kuss H.J., Mavrogiorgou P., Hegerl U. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl.) 2000, 148:404-411.
16. Gangadhar B.N., Ancy J., Janakiramaiah N., Umapathy C. P300 amplitude in non-bipolar, melancholic depression. J. Affect. Disord. 1993, 28:57-60.
17. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr. Clin. Neurophysiol. 1983, 55:468-484.
18. Işintaş M., Ak M., Erdem M., Oz O., Ozgen F. [Event-related potentials in major depressive disorder: the relationship between P300 and treatment response]. Turk. Psikiyatri. Derg. 2012, 23:33-39.
19. Jaworska N., De Somma E., Blondeau C., Tessier P., Norris S., Fusee W., Smith D., Blier P., Knott V. Auditory P3 in antidepressant pharmacotherapy treatment responders, non-responders and controls. Eur. Neuropsychopharmacol 2013.
20. Kalayam B., Alexopoulos G.S. Prefrontal dysfunction and treatment response in geriatric depression. Arch. Gen. Psychiatry 1999, 56:713-718.
21. Kawasaki T., Tanaka S., Wang J., Hokama H., Hiramatsu K. Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event-related potentials. Psychiatry Clin. Neurosci. 2004, 58:68-75.
22. Kemp A.H., Hopkinson P.J., Hermens D.F., Rowe D.L., Sumich A.L., Clark C.R., Drinkenburg W., Abdi N., Penrose R., McFarlane A., Boyce P., Gordon E., Williams L.M. Fronto-temporal alterations within the first 200ms during an attentional task distinguish major depression, non-clinical participants with depressed mood and healthy controls: a potential biomarker?. Hum. Brain Mapp. 2009, 30:602-614.
23. Kenemans J.L., Kähkönen S. How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology 2011, 36:26-51.
24. Kurth F., Zilles K., Fox P.T., Laird A.R., Eickhoff S.B. A link between the systems: functional differentiation and integration within the human insula revealed by meta-analysis. Brain Struct. Funct. 2010, 214:519-534.
25. Liston C., Chen A.C., Zebley B.D., Drysdale A.T., Gordon R., Leuchter B., Voss H.U., Casey B.J., Etkin A., Dubin M.J. Default mode network mechanisms of transcranial magnetic stimulation in depression. Biol. Psychiatry 2014, 76:517-526.
26. Marcus, M., Yasamy, M.T., Van Ommeren, M., Chisholm, D., Saxena, S., 2012. Depression: a global public health concern. World Health Organization Paper on Depression, 6-8.
27. Mayberg H.S., Silva J.A., Brannan S.K., Tekell J.L., Mahurin R.K., McGinnis S., Jerabek P.A. The functional neuroanatomy of the placebo effect. Am. J. Psychiatry 2002, 159:728.
28. McGrath C.L. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 2013, 70:1.
29. Menon V., Uddin L.Q. Saliency, switching, attention and control: a network model of insula function. Brain Struct. Funct. 2010, 214:655-667.
30. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., Möller H.J., Hegerl U., Pogarell O. Prediction of treatment response in major depression: integration of concepts. J. Affect. Disord. 2007, 98:215-225.
31. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15:1-25.
32. Olbrich S., Arns S.M. EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response. Int. Rev. Psychiatry 2013, 25:604-618.
33. Pascual-Marqui R.D. Review of methods for solving the EEG inverse problem. International. J. Bioelectromagn. 1999, 1:75-86.
34. Pascual-Marqui R.D. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp. Clin. Pharmacol. 2002, 24:5-12.
35. Pascual-Marqui, R.D., 2007. Discrete, 3D Distributed, Linear Imaging Methods of Electric Neuronal Activity. Part 1: Exact, Zero Error Localization. arXiv preprint arXiv:0710.3341.
36. Pascual-Marqui R.D., Esslen M., Kochi K., Lehmann D. Functional imaging with low resolution brain electromagnetic tomography (LORETA): review, new comparisons, and new validation. Jpn. J. Clin. Neurophysiol. 2002, 30:81-94.
37. Pascual-Marqui R.D., Michel C.M., Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int. J. Psychophysiol. 1994, 18:49-65.
38. Paul R.H., Gunstad J., Cooper N., Williams L.M., Clark C.R., Cohen R.A., Lawrence J.J., Gordon E. Cross-cultural assessment of neuropsychological performance and electrical brain function measures: additional validation of an international brain database. Int. J. Neurosci. 2007, 117:549-568.
39. Röschke J., Wagner P. A confirmatory study on the mechanisms behind reduced P300 waves in depression. Neuropsychopharmacology 2003, 28(Suppl. 1):S9-S12.
40. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackeim H.A., Kupfer D.J., Luther J., Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 2006, 163:1905-1917.
41. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:22-33.
42. Spronk D., Arns M., Barnett K.J., Cooper N.J., Gordon E. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. J. Affect. Disord. 2011, 128:41-48.
43. Strik W.K., Fallgatter A.J., Brandeis D., Pascual-Marqui R.D. Three-dimensional tomography of event-related potentials during response inhibition: evidence for phasic frontal lobe activation. Electroencephalogr. Clin. Neurophysiol. 1998, 108:406-413.
44. Urretavizcaya M., Moreno I., Benlloch L., Cardoner N., Serrallonga J., Menchón J.M., Vallejo J. Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitude. J. Affect. Disord. 2003, 74:293-297.
45. van Dinteren R., Arns M., Jongsma M., Kessels R. Combined frontal and parietal P300 amplitudes indicate compensated cognitive processing across the lifespan. Front. Aging Neurosci. 2014, 6:294.
46. van Dinteren R., Arns M., Jongsma M.L.A., Kessels R.P.C. P300 development across the lifespan: a systematic review and meta-analysis. PLoS One 2014, 9:e87347.
47. Vandoolaeghe E., van Hunsel F., Nuyten D., Maes M. Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude. J. Affect. Disord. 1998, 48:105-113.
48. Ward A.M., Schultz A.P., Huijbers W., Van Dijk K.R., Hedden T., Sperling R.A. The parahippocampal gyrus links the default-mode cortical network with the medial temporal lobe memory system. Hum. Brain Mapp. 2014, 35:1061-1073.
49. Williams L.M., Rush A.J., Koslow S.H., Wisniewski S.R., Cooper N.J., Nemeroff C.B., Schatzberg A.F., Gordon E. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials 2011, 12:4.
50. Williams L.M., Simms E., Clark C.R., Paul R.H., Rowe D., Gordon E. The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: "neuromarker". Int. J. Neurosci. 2005, 115:1605-1630.